Both FDA-approved and -unapproved FMT products should play a role in preventing C. diff infections, according to Dr. Jessica Allegretti.
Upcoming AGA guidelines on moderate-to-severe ulcerative colitis help to make sense of new therapies and mechanisms while advising on treatment strategies such as combinations and de-escalation.
Inflammatory bowel disease (IBD) continues to be one of the hottest topics at DDW. This year, World IBD Day — Sunday, May 19 — falls during the meeting. See what we have planned.
Keep the momentum going from the Crohn’s & Colitis Congress®! DDW 2024 will offer a variety of IBD-related programming.
New treatment approaches should consider matching treatment intensity to inflammatory burden, Dr. David Rubin asserts.
Keep the momentum from Crohn’s & Colitis going — learn the latest advances in inflammatory bowel diseases (IBD) at DDW 2023.
Dr. James D. Lewis reviews data on diets for IBD patients and stresses that the patient’s goals and ability to adhere to the diet can be just as important as the diet itself.
More courses of antibiotics = increased risk, but the type of antibiotic mattered.
Learn the latest advances in inflammatory bowel diseases (IBD) and participate in impactful conversations at this year’s meeting.
The Crohn’s and Colitis Congress is over, but you get more IBD education at DDW 2021.
